Botox for Chronic Migraine in St. Louis

Botox does not treat a migraine that has already started. It is a preventive treatment. You get it on a schedule to cut how many headache days you have each month. It blocks the release of chemical messengers that carry pain signals at the nerve endings in the head and neck. That calms the oversensitive nerves that keep the migraine cycle running. The cosmetic effect is a side note, not the goal.

This matters more than most patients are told. Botox is FDA-approved for chronic migraine. That means 15 or more headache days per month, with at least 8 of them having migraine features, for three months running. It is not approved for episodic migraine. The trials did not show benefit in that group. If you have fewer than 15 headache days a month, we will tell you. Then we will look at other options. We will not treat you with something the evidence does not back. Keep a headache diary before your visit. It is the single most useful thing you can do.

We follow the PREEMPT protocol. That is 31 shots of a fixed dose spread across seven muscle areas: the forehead, temples, back of the head, neck and upper shoulders. The needles are very fine. The whole visit takes about fifteen minutes. No sedation is used, and you drive yourself home. Treatment repeats every twelve weeks.

Benefit builds. It does not show up all at once. Many patients notice little after the first round and a clearer drop after the second or third. That is why the protocol is built as a series. Neck soreness for a few days is the most common side effect. If your headaches have a strong cluster or face-pain part, we may combine or compare this with a sphenopalatine ganglion block. Ongoing head and neck pain from the cervical spine (the neck bones) is checked separately, because it does not respond to Botox the same way.

Botulinum toxin type A is best known for blocking acetylcholine release where nerve meets muscle. That is how it relaxes muscle. But that is not what matters in migraine. The toxin cuts SNAP-25, a protein in the SNARE complex. Tiny sacs inside the nerve need that protein to merge with the cell membrane and dump their contents. Sensory nerves use the same machinery.

Blocking it in the trigeminal nerve endings of the face and scalp cuts the release of neuropeptides (pain chemicals), including CGRP and substance P. Those chemicals make the outer nerves oversensitive. That steady input from the outside keeps central sensitization going in the trigeminocervical complex, a pain hub in the brainstem. In that state, ordinary stimuli like touch and light start to register as pain. Turning down the outside input is how a drug injected into scalp and neck tissue changes a problem made in the brain.

This also explains the twelve-week gap. It is the time the nerve needs to rebuild working SNAP-25 and restore normal release. It is not how long the muscle stays relaxed.

The PREEMPT program tested this in chronic migraine and found a benefit. The same approach studied in episodic migraine did not separate from placebo. That is not a licensing technicality. It follows from how the drug works. In chronic migraine, central sensitization is already set in. Cutting the outside input that feeds it has something to act on. In episodic migraine that state is not always present. So there is less for the toxin to interrupt between attacks.

It is the clearest example on this site of why we ask for a headache diary before treating. The number of headache days is not paperwork for the insurer. It is the number that predicts whether the treatment can work at all.